Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

NCT01113515 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Esmolol hydrochloride
DRUG: Esmolol hydrochloride
DRUG: Esmolol hydrochloride
DRUG: Placebo gel

Sponsor

Novalead Pharma Private Limited